Medical Developments (MVP.AX)
Trading: SELL @ $3.8
Signal Strength: WEAK
Indicator MUST BE USED in additional to another technical indicator to confirmation for trading entry. Indicator can be applied to the short term timeframe but is only able to give and indication of the strength of the buyers versus sellers at the market close. This bar analysis can provide guidance on the daily battle between sellers and buyers from the companies recent trading.
Medical Developments (ASX:MVP) sellers are keener than buyers and are driving the price down. There has been 2 consecutive days of price decline for MVP adding strength to a downtrend in the first timeframe. The biggest downward movement this month has been -6.1 & the greatest daily negative change this year has been -19.5. The longest consecutive downswing rally over the last 12 months has been 5 days giving a total rally downward movement of -19.7%. This quarter, the largest downswing rally has been 5 days giving a total rally downward movement of -13.9%. The loss ratio for price rise in the first timeframe for the last 12 months is 0x giving a total win/loss ratio of 0.3x. Over the last month the average daily downward movement has been -2.400000%
The only price most market participants look at is the closing price in relation to the previous day’s close. As such the position of the close has the ability to highlight recent performance and indirectly the keenness of traders.
[Calculations] Close Today Versus Close Yesterday (CTCY):
1) [Close] > [Close Yesterday] = Buyers keener than sellers;
2) [Close] < [Close Yesterday] = Sellers keener than buyers;
3) [Close] = [Close Yesterday] = Neither are keener
PROFILE: Medical Developments (MVP.AX)
Stock Exchange: ASX
Company: Medical Developments
Ticker Codes: | MVP.AX | ASX:MVP |
Medical Developments International Limited manufactures and distributes pharmaceutical drugs, and medical and veterinary equipment. The company operates in three segments: Pharmaceuticals, Medical Devices, and Veterinary products. It offers asthma and COPD pressurized metered dose inhalers, as well as masks and peak flow meters for asthma management; Penthrox, a prescription only medicine for acute pain; medical devices; and various veterinary anesthetic machines to veterinarians. The company operates in Australia, Europe, North America, the Middle East, Asia, and South Africa. Medical Developments International Limited is headquartered in Scoresby, Australia.
|DCN Dacian Gold||2||-0.5||1,181,693||-1||BEARISH|
|EVN Evolution Mining||3.29||-0.6||6,497,397||-1||BEARISH|
|IPL Incitec Pivot||3.48||-0.6||9,954,731||-1||BEARISH|
|APE Ap Eagers Holdings||6.28||-0.8||57,557||-1||BEARISH|